Chief allergist-immunologist of the MC Hospital of the PAA of RK Galiya Tussupbekova took part in the annual Congress of the European Academy of Allergists and Clinical Immunologists (EAACI 2024).
This year the EAACI Congress was held in Valencia (Spain). At the event, she spoke about approaches to treating patients with severe allergies and asthma and shared her experience. In addition, Galiya Tussupbekova gave a presentation on “The first experience of using biological therapy with dupilumab in combination with allergen-specific immunotherapy in a patient with severe bronchial asthma and atopic dermatitis, refractory to standard therapy”.
The European Academy Congress is a platform that brings together scientists, healthcare professionals and other stakeholders involved in allergy and clinical immunology to establish partnerships and exchange knowledge and experience. It should be noted that the Congress is held under the slogan “Revolutionizing patient care through science”.
Participation in it will allow you to expand the boundaries of knowledge, get acquainted with new directions and innovations in the field of clinical immunology and allergy, and introduce new approaches to diagnosis and treatment in our country. It is important to note that the doctors of the Medical Center Hospital are constantly improving their knowledge and qualifications, competence and professional level, without losing sight of innovations in the field of medicine. They regularly visit leading clinics and centers near and far abroad, exchange experiences and improve their knowledge.
